Supernus Pharmaceuticals
SUPN
SUPN
228 hedge funds and large institutions have $1.64B invested in Supernus Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 101 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 233 → 228 (-5)
2.66% less ownership
Funds ownership: 103.83% → 101.17% (-2.7%)
33% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 101
Holders
228
Holding in Top 10
3
Calls
$5.37M
Puts
$4M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$14.2M | |
| 3 | +$9.24M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$8.11M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.77M |
Top Sellers
| 1 | -$33.5M | |
| 2 | -$8.62M | |
| 3 | -$7.55M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.83M |
| 5 |
RA
Royce & Associates
New York
|
-$6.6M |